April 25th 2024
At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.
(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(COPE Credit) Community Practice Connections™: Restoring the Surface – Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment
View More
(CME/CNE Credit) Community Practice Connections™: Restoring the Surface Impact of Preservatives and Novel Formulations in First Line Treatments for Dry Eye Disease
View More
(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease
View More
18th Annual Controversies in Modern Eye Care
May 4, 2024
Register Now!
(COPE Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations
View More
(CME Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
2nd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
May 18-19, 2024
Register Now!
(COPE Credit) Learning About the Lid – Optimizing Recognition, Diagnosis, and Treatment of Demodex Blepharitis & Blepharoptosis
View More
(CME Credit) Virtual Case Studies™ in Cataract Surgery: Selecting Surgical Techniques and Preventing Intra-Operative Complications
View More
(COPE Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
Neurotrophic Keratitis Management: How Early Intervention Can Make a Difference
View More
(CME Credit) Clinical Crossroads: Navigating Neurotrophic Keratitis – The Importance of Avoiding Pitfalls and Ensuring Early Intervention
View More
1st Annual IKA Keratoconus Symposium: Front to Back and Everything In Between
View More
17th Annual Controversies in Modern Eye Care
View More
Cases & Conversations™: Addressing Challenges In The Diagnosis And Management Of Neurotrophic Keratitis
View More
(CME Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(COPE Credit) Community Practice Connections™: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connection™: Pearls in Co-managing Glaucoma – Multidisciplinary Management in a Multitude of Treatment Options
View More
(COPE Credit) Community Practice Connection™: Pearls in Co-managing Glaucoma – Multidisciplinary Management in a Multitude of Treatment Options
View More
Thyroid Eye Disease: The Masquerading Eye Disorder—A Guide to Collaborative Care and Accurate Diagnosis
View More
(CME Credit) Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
AAOphth says marijuana is not proven treatment for glaucoma
July 8th 2014The American Academy of Ophthalmology (AAOphth) has reiterated its stance on medical marijuana for the treatment of glaucoma, stating that it finds no scientific evidence that marijuana is an effective long-term treatment for the disease, particularly when compared to the current prescription medication and surgical treatment available.
Ophthalmologists and ophthalmology trainees underestimate glaucoma risk
July 2nd 2014A study from the Centre for Eye Research Australia at the University of Melbourne found that comprehensive ophthalmologist and ophthalmology trainees who participated in an online multinational study to assess optic discs were about twice as likely to underestimate as to overestimate glaucoma risk.
Glaucoma drug may reverse obesity-related vision loss
May 30th 2014A recent study funded by the National Institute of Health found that the glaucoma drug acetazolamide (Diamox, Duramed Pharmaceuticals), when combined with a weight loss plan, can improve vision for patients with idiopathic intracranial hypertension (IIH).
Promoting practice growth by investing in optical
April 21st 2014I sometimes wonder why, in the rush to build the medical model, so many of my colleagues seemingly abandon the retail aspects of our profession. Many ODs seem to want to forget or diminish that our historical contribution to vision has been mainly centered around the correction, refractive, and binocular vision function and development.
Maximum medical therapy in glaucoma
February 13th 2014A few months ago, I began to see what may be a little more progression on her OCT studies. I’m fairly confident that we’re in a good place right now as far as compliance is concerned, and I’m entering a crossroads with her regarding possibly adding therapy vs. getting a consult for a laser procedure, such as selective laser trabeculoplasty (SLT), vs. getting a cataract consult.
Ophthalmic drug market expected to reach $21.6 billion globally in 2018
February 4th 2014According to a new market report published by Transparency Market Research the global ophthalmic drugs market was valued at $16 billion in 2012 and is expected to reach an estimated value of $21.6 billion in 2018.
IOP as a cornerstone to glaucoma management
January 2nd 2014The measurement and management of intraocular pressure (IOP) in patients with glaucoma is critical. Even with the onslaught of new technologies to monitor progression and make earlier diagnoses, IOP remains a crucial data point in the optometric examination.
Prevent Blindness declares January National Glaucoma Awareness Month
December 30th 2013Prevent Blindness and other eye health organizations have declared January as National Glaucoma Awareness Month. Prevent Blindness seeks to educate the public on the second leading cause of blindness, following cataracts, by providing free resources via online or by mail through its Glaucoma Learning Center.
ODs must be responsible for public misconception about optometry
December 20th 2013I didn’t get up screaming. I didn’t hurl my computer across the room. I didn’t even let my inferiority complex show through the emotions I was feeling. Instead, I calmly and politely wrote a short letter to the news organization explaining what optometrists are, and that glaucoma was what I, as an optometrist, spent most of my days dealing with.
Better imaging detects glaucoma progression earlier
October 24th 2013It may be possible to view early changes in the eye before the clinical symptoms of glaucoma become apparent. A better understanding of the structural changes in glaucoma could potentially allow for a better diagnosis of the disease. Using imaging devices, such as the adaptive optics scanning laser ophthalmoscope (AOSLO), clinicians can view sharper and higher-resolution images of the eye than current clinical instruments.